My research is focused on the studying the cellular and molecular mechanisms regulating the development of cardiometabolic disorders and identifying novel pharmacologic strategies to combat cardiovascular diseases such as atherosclerosis, endothelial and vascular dysfunction in diabetic, obese and aging patients. Currently we are exploring the role of gut microbe-derived metabolites in endothelial and vascular cell signaling.